|
Video: What is a Stock Split?
|
|
Interpace Biosciences engages in oncology by providing services from early diagnosis and prognostic planning to targeted therapeutic applications through its clinical and pharma services. Co.'s commercialized molecular diagnostic tests include: PancraGEN®, which is a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians assess risk of pancreaticobiliary cancers using its PathFinderTG® platform; and ThyGeNEXT®, which is an oncogenic mutation panel that helps identify malignant thyroid nodules. Through its pharma services, Co. provides ancillary services, including: biorepository, clinical trial logistics, clinical trial design, and bioinformatics analysis. According to our IDXG split history records, IDXG has had 2 splits. | |
|
IDXG (IDXG) has 2 splits in our IDXG split history database. The first split for IDXG took place on December 29, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of IDXG owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. IDXG's second split took place on January 15, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of IDXG owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 10 share position following the split.
When a company such as IDXG conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IDXG split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IDXG shares, starting with a $10,000 purchase of IDXG, presented on a split-history-adjusted basis factoring in the complete IDXG split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/21/2014 |
|
End date: |
03/01/2021 |
|
Start price/share: |
$539.00 |
|
End price/share: |
$3.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.44% |
|
Average Annual Total Return: |
-52.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$56.40 |
|
Years: |
6.87 |
|
|
|
Date |
Ratio |
12/29/2016 | 1 for 10 | 01/15/2020 | 1 for 10 |
|
|